Blood Cancer Journal (Aug 2024)

Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease

  • Jialing Lu,
  • Xiebing Bao,
  • Jihao Zhou,
  • Xiaoli Li,
  • Zhewei He,
  • Yujie Ji,
  • Shengli Xue,
  • Suning Chen,
  • Depei Wu,
  • Qi Hu,
  • Peng Ke,
  • Xiao Ma

DOI
https://doi.org/10.1038/s41408-024-01127-2
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 5

Abstract

Read online

No abstracts available.